CHENNAI: After a nine-year-old boy from Thirvur in Tiruvallur district died due to Guillain-Barre Syndrome (GBS) — a rare ...

The dream of a young child from Knoxville who spent much of his early life battling a rare disease is coming true with some ...

Conditions like lupus, Sjögren’s syndrome, or polymyalgia rheumatica can cause widespread fatigue alongside other symptoms ...

The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...

Thirty-seven sick and wounded Palestinians have left Gaza for medical treatment in Egypt following the reopening of the Rafah ...

Learn about dermatomyositis and the remarkable journey of Audrey Gouskos. Discover how St. Michael's Hospital has provided ...

This SPA agreement marks an important milestone in the development of Descartes-08 for MG, providing critical regulatory clarity and a clear path toward potential approval,” said Carsten Brunn, Ph.D., ...

Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic ...

Japan’s Nippon Shinyaku is continuing to scoop up the international rights to some intriguing drugs, this time penning a $686 million biobucks deal for AB2 Bio’s late-stage autoimmune disease therapy.

After being diagnosed with a rare disease—indolent systemic mastocytosis (ISM)—and starting on a treatment that has reduced her ISM symptoms, she continues to adapt and is inspired to help ...

THEY KNEW IT WAS AUTOIMMUNE, BUT EVERY TIME THEY TRIED ... THEN IN 2019, AN ANSWER FINALLY ARRIVED THROUGH THE UNDIAGNOSED DISEASES NETWORK, ROSA SYNDROME, A NAME AS COMPLEX AS THE CONDITION ...